New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 14, 2012
07:12 EDTCVSCVS Caremark upgraded to Outperform from Neutral at Macquarie
Macquarie expects CVS Caremark's long-term growth to benefit from Healthcare reform laws and for shares to outperform based on limited 2013 negative earnings revisions, a stronger 2014 PBM selling season, and generics. Price target raised to $55 from $50.
News For CVS From The Last 14 Days
Check below for free stories on CVS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2014
08:33 EDTCVSCVS Caremark announces new clinical affiliation with MedStar Health
Subscribe for More Information
August 24, 2014
21:53 EDTCVSNational Association of Chain Drug Stores to hold an expo
2014 NACDS Total Store Expo to be held in Boston on August 23-25.
August 18, 2014
08:31 EDTCVSCVS Caremark's Accordant Health receives NCQA accreditation
CVS Caremark announced that its Accordant Health Services division has received full NCQA Patient and Practitioner Oriented Disease Management accreditation for programs to support: Epilepsy, Rheumatoid Arthritis, Multiple Sclerosis, Crohn's Disease, Ulcerative Colitis, Parkinson's Disease, Systemic Lupus Erythematosus, Myasthenia Gravis, Sickle Cell Disease, Cystic Fibrosis, Hemophilia, Scleroderma, Polymyositis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Amyotrophic Lateral Sclerosis, Dermatomyositis, and Gaucher Disease.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use